Follow
Kunal Dhiman
Kunal Dhiman
Research Fellow, Deakin University and Western Health
Verified email at deakin.edu.au
Title
Cited by
Cited by
Year
A review on the medicinally important plants of the family Cucurbitaceae.
K Dhiman, A Gupta, DK Sharma, NS Gill, A Goyal
2282012
Cerebrospinal fluid biomarkers for understanding multiple aspects of Alzheimer’s disease pathogenesis
K Dhiman, K Blennow, H Zetterberg, RN Martins, VB Gupta
Cellular and molecular life sciences 76, 1833-1863, 2019
1072019
Cerebrospinal fluid neurofilament light concentration predicts brain atrophy and cognition in Alzheimer's disease
K Dhiman, VB Gupta, VL Villemagne, D Eratne, PL Graham, C Fowler, ...
Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring 12 (1 …, 2020
962020
Evaluation of therapeutic potential of traditionally consumed Cucumis melo seeds
NS Gill, J Bajwa, K Dhiman, P Sharma, S Sood, PD Sharma, B Singh, ...
Deakin University, 2011
632011
Evaluation of antioxidant and antiulcer activity of traditionally consumed Cucumis melo seeds.
NS Gill, J Bajwa, P Sharma, K Dhiman, S Sood, PD Sharma, B Singh, ...
572011
Evaluation of free radical scavenging, anti-inflammatory and analgesic potential of Benincasa hispida seed extract.
NS Gill, K Dhiman, J Bajwa, P Sharma, S Sood
562010
Comparative analysis of aducanumab, zagotenemab and pioglitazone as targeted treatment strategies for Alzheimer’s disease
M Abyadeh, V Gupta, V Gupta, N Chitranshi, Y Wu, A Amirkhani, ...
Aging and disease 12 (8), 1964, 2021
542021
A pilot study of the utility of cerebrospinal fluid neurofilament light chain in differentiating neurodegenerative from psychiatric disorders: A ‘C-reactive protein’for …
D Eratne, SM Loi, N Walia, S Farrand, QX Li, S Varghese, M Walterfang, ...
Australian & New Zealand Journal of Psychiatry 54 (1), 57-67, 2020
542020
Free radical scavenging potential and total phenolic and flavonoid content of Ziziphus mauritiana and Ziziphus nummularia fruit extracts.
AG Dureja, K Dhiman
International Journal of Green Pharmacy (Medknow Publications & Media Pvt …, 2012
492012
Cerebrospinal fluid neurofilament light chain differentiates primary psychiatric disorders from rapidly progressive, Alzheimer's disease and frontotemporal disorders in …
D Eratne, SM Loi, QX Li, C Stehmann, CB Malpas, A Santillo, S Janelidze, ...
Alzheimer's & Dementia 18 (11), 2218-2233, 2022
362022
Evaluation of free radical scavenging and antiulcer potential of methanolic extract of Benincasa hispida seeds
NS Gill, K Dhiman, P Sharma, J Bajwa, S Sood, PD Sharma, B Singh, ...
Deakin University, 2011
222011
Neuroserpin, a crucial regulator for axogenesis, synaptic modelling and cell–cell interactions in the pathophysiology of neurological disease
A Godinez, R Rajput, N Chitranshi, V Gupta, D Basavarajappa, S Sharma, ...
Cellular and Molecular Life Sciences 79 (3), 172, 2022
162022
Study on Cucumis melo var. utilissimus seeds for the therapeutic potential
NS Gill, P Sharma, J Bajwa, K Dhiman, S Sood, PD Sharma, M Bali
Deakin University, 2010
122010
Cerebrospinal fluid neurofilament light concentration predicts brain atrophy and cognition in Alzheimer’s disease. Alzheimers Dement Diagn Assess Dis Monit 2020; 12: e12005
K Dhiman, VB Gupta, VL Villemagne, D Eratne, PL Graham, C Fowler, ...
9
Decreased cerebrospinal fluid neuronal pentraxin receptor is associated with PET-Aβ load and cerebrospinal fluid Aβ in a pilot study of Alzheimer’s disease
B Lim, C Fowler, QX Li, C Rowe, K Dhiman, VB Gupta, CL Masters, ...
Neuroscience letters 731, 135078, 2020
82020
A comprehensive insight into the development of animal models for obesity research
A Goyal, AG Dureja, DK Sharmaρ, K Dhiman
Global J. Med. Res. 12, 39-44, 2012
82012
Elevated levels of synaptic protein GAP‐43 associate with brain tauopathy, atrophy and cognition in Alzheimer’s disease: Biomarkers (non‐neuroimaging)/Differential diagnosis
K Dhiman, VLL Villemagne, D Eratne, PL Graham, CJ Fowler, P Bourgeat, ...
Alzheimer's & Dementia 16, e044098, 2020
52020
Cerebrospinal fluid neurofilament light predicts risk of dementia onset in cognitively healthy individuals and rate of cognitive decline in mild cognitive impairment: a …
K Dhiman, VL Villemagne, C Fowler, P Bourgeat, QX Li, S Collins, ...
Biomedicines 10 (5), 1045, 2022
32022
Cerebrospinal fluid levels of fatty acid–binding protein 3 are associated with likelihood of amyloidopathy in cognitively healthy individuals
K Dhiman, VL Villemagne, C Fowler, P Bourgeat, QX Li, S Collins, ...
Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring 14 (1 …, 2022
32022
Neurofilament light chain in psychiatric and neurodegenerative disorders: A ‘c‐reactive protein’for the brain? Biomarkers (non‐neuroimaging)/plasma/serum/urine biomarkers
D Eratne, SM Loi, A Santillo, QX Li, C Chadunow, C Stehmann, ...
Alzheimer's & Dementia 16, e041347, 2020
12020
The system can't perform the operation now. Try again later.
Articles 1–20